Mark M. Blatter

6.0k total citations · 1 hit paper
84 papers, 4.2k citations indexed

About

Mark M. Blatter is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Mark M. Blatter has authored 84 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Epidemiology, 36 papers in Microbiology and 14 papers in Infectious Diseases. Recurrent topics in Mark M. Blatter's work include Bacterial Infections and Vaccines (35 papers), Pneumonia and Respiratory Infections (34 papers) and Influenza Virus Research Studies (20 papers). Mark M. Blatter is often cited by papers focused on Bacterial Infections and Vaccines (35 papers), Pneumonia and Respiratory Infections (34 papers) and Influenza Virus Research Studies (20 papers). Mark M. Blatter collaborates with scholars based in United States, Belgium and United Kingdom. Mark M. Blatter's co-authors include Keith S. Reisinger, Gary Dubin, Anne Schuind, Bruce L. Innis, Paulo Naud, Newton Sérgio de Carvalho, Cecília Roteli-Martins, Júlio César Teixeira, Cosette M. Wheeler and Eduardo L. Franco and has published in prestigious journals such as The Lancet, PEDIATRICS and American Journal of Public Health.

In The Last Decade

Mark M. Blatter

84 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

2004 1.2k citations Diane M. Harper, Eduardo L. Franco et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark M. Blatter United States	32	3.1k	925	543	540	489	84	4.2k
Johannes G. Liese Germany	35	2.5k 0.8×	996 1.1×	329 0.6×	811 1.5×	947 1.9×	133	4.3k
David W. Scheifele Canada	42	4.0k 1.3×	2.1k 2.3×	371 0.7×	1.1k 2.1×	569 1.2×	239	5.6k
Paula Ray United States	30	4.2k 1.4×	1.9k 2.1×	143 0.3×	623 1.2×	239 0.5×	47	5.2k
Jussi Mertsola Finland	47	5.1k 1.7×	3.8k 4.1×	361 0.7×	1.1k 2.1×	596 1.2×	184	7.1k
Harry Keyserling United States	36	3.4k 1.1×	685 0.7×	303 0.6×	1.7k 3.2×	965 2.0×	87	5.6k
Christoph Aebi Switzerland	40	2.4k 0.8×	533 0.6×	326 0.6×	931 1.7×	462 0.9×	168	4.3k
John Hansen United States	24	4.1k 1.3×	1.9k 2.1×	299 0.6×	569 1.1×	212 0.4×	63	4.8k
David P. Greenberg United States	35	3.3k 1.1×	1.5k 1.6×	137 0.3×	953 1.8×	426 0.9×	98	4.4k
Xavier Sáez‐Llorens Panama	36	2.1k 0.7×	1.4k 1.5×	401 0.7×	1.8k 3.3×	509 1.0×	124	4.7k
Colin D. Marchant United States	33	2.2k 0.7×	1.2k 1.3×	372 0.7×	420 0.8×	189 0.4×	78	3.4k

Countries citing papers authored by Mark M. Blatter

Since Specialization

Citations

This map shows the geographic impact of Mark M. Blatter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark M. Blatter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark M. Blatter more than expected).

Fields of papers citing papers by Mark M. Blatter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark M. Blatter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark M. Blatter. The network helps show where Mark M. Blatter may publish in the future.

Co-authorship network of co-authors of Mark M. Blatter

This figure shows the co-authorship network connecting the top 25 collaborators of Mark M. Blatter. A scholar is included among the top collaborators of Mark M. Blatter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark M. Blatter. Mark M. Blatter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ramanakumar, Agnihotram V., Paulo Naud, Cecília Roteli-Martins, et al.. (2016). Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial. BMJ Open. 6(8). e011371–e011371. 27 indexed citations

Blatter, Mark M., et al.. (2014). Quadrivalent meningococcal (MenACWY-TT) conjugate vaccine or a fourth dose of H. influenzae–N. meningitidis C/Y conjugate vaccine (HibMenCY-TT) is immunogenic in toddlers who previously received three doses of HibMenCY-TT in infancy. Vaccine. 33(7). 933–941. 6 indexed citations

Lasekan, John B., Jeffery Oliver, Jane D. Carver, et al.. (2014). Milk Protein–Based Infant Formula Containing Rice Starch and Low Lactose Reduces Common Regurgitation in Healthy Term Infants: A Randomized, Blinded, and Prospective Trial. Journal of the American College of Nutrition. 33(2). 136–146. 12 indexed citations

Blatter, Mark M., Nicola P. Klein, Martin Schear, et al.. (2012). Immunogenicity and Safety of Two Tetravalent (Measles, Mumps, Rubella, Varicella) Vaccines Coadministered With Hepatitis A and Pneumococcal Conjugate Vaccines to Children Twelve to Fourteen Months of Age. The Pediatric Infectious Disease Journal. 31(8). e133–e140. 20 indexed citations

Domachowske, Joseph B., Mark M. Blatter, Vijayalakshmi Chandrasekaran, et al.. (2012). A Randomized, Controlled Trial in Children to Assess the Immunogenicity and Safety of a Thimerosal-free Trivalent Seasonal Influenza Vaccine. The Pediatric Infectious Disease Journal. 31(6). 605–615. 3 indexed citations

Roteli-Martins, Cecília, Newton Sérgio de Carvalho, Paulo Naud, et al.. (2011). Prevalence of Human Papillomavirus Infection and Associated Risk Factors in Young Women in Brazil, Canada, and the United States. International Journal of Gynecological Pathology. 0(0). 173–184. 29 indexed citations

Halperin, Scott A., Shelly McNeil, Joanne M. Langley, et al.. (2011). Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap) 4–5 years after a previous dose. Vaccine. 29(46). 8459–8465. 33 indexed citations

Plennevaux, Eric, et al.. (2011). Influenza A (H1N1) 2009 two-dose immunization of US children: An observer-blinded, randomized, placebo-controlled trial. Vaccine. 29(8). 1569–1575. 30 indexed citations

Blatter, Mark M. & Bradley J. Monk. (2008). The Pediatrician's Role in Preventing Cervical Cancer. Clinical Pediatrics. 47(7). 627–638. 1 indexed citations

10.

Connor, Bradley A., Mark M. Blatter, Jiřı́ Beran, Bin Zou, & Andrew F. Trofa. (2007). Rapid and Sustained Immune Response Against Hepatitis A and B Achieved With Combined Vaccine Using an Accelerated Administration Schedule. Journal of Travel Medicine. 14(1). 9–15. 22 indexed citations

11.

Pichichero, Michael E., Henry H. Bernstein, Mark M. Blatter, et al.. (2007). Immunogenicity and Safety of a Combination Diphtheria, Tetanus Toxoid, Acellular Pertussis, Hepatitis B, and Inactivated Poliovirus Vaccine Coadministered with a 7-Valent Pneumococcal Conjugate Vaccine and a Haemophilus Influenzae Type b Conjugate Vaccine. The Journal of Pediatrics. 151(1). 43–49.e2. 25 indexed citations

12.

Harper, Diane M., Eduardo L. Franco, Cosette M. Wheeler, et al.. (2005). Efficacy of a Bivalent L1 Virus-Like Particle Vaccine in Prevention of Infection With Human Papillomavirus Types 16 and 18 in Young Women: A Randomized, Controlled Trial. Obstetrical & Gynecological Survey. 60(5). 303–305. 12 indexed citations

13.

Pichichero, Michael E., Mark M. Blatter, Keith S. Reisinger, et al.. (2002). Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccination. The Pediatric Infectious Disease Journal. 21(9). 854–859. 41 indexed citations

14.

Cordle, Christopher T., Timothy R. Winship, Joseph P. Schaller, et al.. (2002). Immune Status of Infants Fed Soy‐Based Formulas With or Without Added Nucleotides for 1 Year: Part 2: Immune Cell Populations. Journal of Pediatric Gastroenterology and Nutrition. 34(2). 145–153. 3 indexed citations

15.

Gillman, Sherwin A., Mark M. Blatter, John J. Condemi, et al.. (2002). The Health-Related Quality of Life Effects of Once-Daily Cetirizine HCl Syrup in Children with Seasonal Allergic Rhinitis. Clinical Pediatrics. 41(9). 687–696. 15 indexed citations

16.

Rothstein, Edward, Edwin L. Anderson, Michael D. Decker, et al.. (1999). An acellular pertussis vaccine in healthy adults: safety and immunogenicity. Vaccine. 17(23-24). 2999–3006. 22 indexed citations

17.

Halsey, Neal A., et al.. (1997). Inactivated poliovirus vaccine alone or sequential inactivated and oral poliovirus vaccine in two-, four- and six-month-old infants with combination Haemophilus influenzae type b/hepatitis B vaccine. The Pediatric Infectious Disease Journal. 16(7). 675–679. 24 indexed citations

18.

Watson, Barbara, Edward Rothstein, Hans‐Gert Bernstein, et al.. (1995). Safety and Cellular and Humoral Immune Responses of a Booster Dose of Varicella Vaccine 6 Years after Primary Immunization. The Journal of Infectious Diseases. 172(1). 217–219. 52 indexed citations

19.

Chan, Kenny H., et al.. (1993). Comparative study of sultamicilln and amoxicillin-clavulanate. The Pediatric Infectious Disease Journal. 12(1). 24–28. 18 indexed citations

20.

Glodé, Mary P., Keith S. Reisinger, Mark M. Blatter, et al.. (1992). Safety and immunogenicity of acellular pertussis vaccine combined with diphtheria and tetanus toxoids in 17− to 24-month-old children. The Pediatric Infectious Disease Journal. 11(7). 530–534. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact